APPLIED THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.31 USD | -3.36% |
|
-11.08% | +28.21% |
| Apr. 15 | Applied Therapeutics, Inc. Announces Management Changes | CI |
| Mar. 28 | Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review | DJ |
Chart calendar Applied Therapeutics, Inc.
f89ca7b0b8.qfhhCBSqGr7lPWUutRejZfa_y5G-X_iaTtLnsW0YO1k.2K4UbFrod8udVFFL8FTPOqfIhPTyDa7vN7qdhDwgYxzYnRtQXeNrjJx0Bg~b04f9d4513196925d021449dc9100240
Upcoming events on Applied Therapeutics, Inc.
Past events on Applied Therapeutics, Inc.
| 2024-04-08 08:30 am | American College of Cardiology Scientific Meeting |
| 2024-03-06 07:00 am | Q4 2023 Earnings Release |
| 2024-02-15 08:30 am | Business Update Call |
| 2023-11-09 02:00 pm | UBS BioPharma Conference |
| 2023-11-09 07:31 am | Q3 2023 Earnings Release |
| 2023-11-07 08:00 am | Investor Meeting - Key Opinion Leaders |
| 2023-10-05 12:15 pm | European Association for the Study of Diabetes Meeting |
| 2023-10-05 11:55 am | European Association for the Study of Diabetes Meeting |
| 2023-10-05 11:30 am | European Association for the Study of Diabetes Meeting |
| 2023-08-10 07:00 am | Q2 2023 Earnings Release |
| 2023-06-26 06:15 pm | American Diabetes Association Meeting |
| 2023-06-26 02:30 pm | American Diabetes Association Scientific Session - Poster No 450 |
| 2023-06-24 02:30 pm | American Diabetes Association Scientific Session - Poster No 1238 |
| 2023-06-20 03:30 am | Peripheral Nerve Society Meeting |
| 2023-06-19 12:15 pm | Peripheral Nerve Society Meeting - Abstract No 1277 |
| 2023-06-19 12:15 pm | Peripheral Nerve Society Meeting - Abstract No 1159 |
| 2023-06-19 06:35 am | Peripheral Nerve Society Meeting |
| 2023-06-19 05:50 am | Peripheral Nerve Society Meeting |
| 2023-06-06 10:00 am | Annual General Meeting |
| 2023-05-11 07:03 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 9,99 10,7 -6.34% | 10,5 |
|
EBITDA Million USD | Released Forecast Spread | -45,6 -40,0 -14.05% | -94,5 -95,3 0.86% | -105 -100 -4.72% | -82,5 -83,4 1.04% | -64,2 -58,2 -10.22% | -67,3 |
|
EBIT Million USD | Released Forecast Spread | -45,6 -40,0 -13.95% | -94,5 -98,8 4.42% | -106 -107 1.29% | -83,0 -86,5 4.09% | -64,5 -61,7 -4.57% | -89,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -45,5 -40,0 -13.82% | -94,0 -101 6.75% | -106 -113 6.76% | -82,5 -87,9 6.14% | -120 -110 -8.91% | -96,1 |
|
Net income Million USD | Released Forecast Spread | -45,5 -40,0 -13.82% | -94,0 -101 6.75% | -106 -113 6.76% | -82,5 -87,9 6.14% | -120 -102 -17.31% | -70,6 |
|
EPS USD | Released Forecast Spread | -3,55 -2,96 -19.75% | -4,28 -4,54 5.72% | -4,12 -4,31 4.46% | -2,18 -2,62 16.93% | -1,42 -1,51 5.65% | -0,71 |
| Announcement Date | 13/03/20 | 18/03/21 | 10/03/22 | 23/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 10,7 0,00 - | 0,00 8,00 - | 0,00 0,00 - | 9,99 0,00 - | 2,50 | 0,00 | 0,75 | 6,24 | 19,9 |
|
EBITDA Million USD | Released Forecast Spread | -27,0 -23,4 -15.41% | -21,0 -15,0 -39.55% | -17,0 | -19,3 | -16,8 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -27,1 -31,1 12.69% | -23,1 -25,1 7.89% | -21,5 -21,9 1.51% | -19,4 -23,6 17.84% | -19,0 -22,5 15.58% | -10,9 -18,3 40.77% | -17,2 -10,8 -58.33% | -15,5 -17,9 13.29% | -21,0 -20,1 -4.52% | -22,2 | -24,8 | -26,9 | -26,3 | -14,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,2 -34,8 22.02% | -23,1 -24,6 6.14% | -25,9 -21,7 -19.1% | -19,1 -22,0 13.03% | -14,4 -19,8 27.24% | -10,1 -18,1 43.88% | -29,6 -10,2 -189.09% | -42,4 -19,0 -122.73% | -37,7 -27,9 -35.14% | -23,8 | -26,2 | -25,2 | -20,9 | -13,7 |
|
Net income Million USD | Released Forecast Spread | -27,2 -34,8 22.02% | -23,1 -24,6 6.14% | -25,9 -21,7 -19.1% | -19,1 -22,0 13.03% | -14,4 -19,8 27.24% | -10,1 -16,3 37.64% | -29,6 -9,21 -221.21% | -42,4 -17,1 -147.49% | -37,7 -20,0 -88.43% | -13,9 | -19,8 | -19,5 | -17,5 | -10,8 |
|
EPS USD | Released Forecast Spread | -1,04 -1,21 14.24% | -0,88 -0,74 -18.39% | -0,96 -0,56 -71.43% | -0,40 -0,52 22.8% | -0,16 -0,51 68.73% | -0,18 -0,43 58.14% | -0,37 -0,17 -117.65% | -0,47 -0,26 -83.51% | -0,33 -0,20 -64.66% | -0,13 | -0,18 | -0,17 | -0,16 | -0,10 |
| Announcement Date | 10/03/22 | 12/05/22 | 12/08/22 | 09/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 06/03/24 | - | - | - | - | - |
More events
Past sector events for Applied Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APLT Stock
- Calendar Applied Therapeutics, Inc.
